Cargando…

Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study

BACKGROUND: Bacterial infections may complicate viral pneumonias. Recent reports suggest that bacterial co-infection at time of presentation is uncommon in coronavirus disease 2019 (COVID-19); however, estimates were based on microbiology tests alone. We sought to develop and apply consensus definit...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaba, Sara M, Jones, George, Helsel, Taylor, Smith, L Leigh, Avery, Robin, Dzintars, Kathryn, Salinas, Alejandra B, Keller, Sara C, Townsend, Jennifer L, Klein, Eili, Amoah, Joe, Garibaldi, Brian T, Cosgrove, Sara E, Fabre, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793465/
https://www.ncbi.nlm.nih.gov/pubmed/33447639
http://dx.doi.org/10.1093/ofid/ofaa578
_version_ 1783633997440483328
author Karaba, Sara M
Jones, George
Helsel, Taylor
Smith, L Leigh
Avery, Robin
Dzintars, Kathryn
Salinas, Alejandra B
Keller, Sara C
Townsend, Jennifer L
Klein, Eili
Amoah, Joe
Garibaldi, Brian T
Cosgrove, Sara E
Fabre, Valeria
author_facet Karaba, Sara M
Jones, George
Helsel, Taylor
Smith, L Leigh
Avery, Robin
Dzintars, Kathryn
Salinas, Alejandra B
Keller, Sara C
Townsend, Jennifer L
Klein, Eili
Amoah, Joe
Garibaldi, Brian T
Cosgrove, Sara E
Fabre, Valeria
author_sort Karaba, Sara M
collection PubMed
description BACKGROUND: Bacterial infections may complicate viral pneumonias. Recent reports suggest that bacterial co-infection at time of presentation is uncommon in coronavirus disease 2019 (COVID-19); however, estimates were based on microbiology tests alone. We sought to develop and apply consensus definitions, incorporating clinical criteria to better understand the rate of co-infections and antibiotic use in COVID-19. METHODS: A total of 1016 adult patients admitted to 5 hospitals in the Johns Hopkins Health System between March 1, 2020, and May 31, 2020, with COVID-19 were evaluated. Adjudication of co-infection using definitions developed by a multidisciplinary team for this study was performed. Both respiratory and common nonrespiratory co-infections were assessed. The definition of bacterial community-acquired pneumonia (bCAP) included proven (clinical, laboratory, and radiographic criteria plus microbiologic diagnosis), probable (clinical, laboratory, and radiographic criteria without microbiologic diagnosis), and possible (not all clinical, laboratory, and radiographic criteria met) categories. Clinical characteristics and antimicrobial use were assessed in the context of the consensus definitions. RESULTS: Bacterial respiratory co-infections were infrequent (1.2%); 1 patient had proven bCAP, and 11 (1.1%) had probable bCAP. Two patients (0.2%) had viral respiratory co-infections. Although 69% of patients received antibiotics for pneumonia, the majority were stopped within 48 hours in patients with possible or no evidence of bCAP. The most common nonrespiratory infection was urinary tract infection (present in 3% of the cohort). CONCLUSIONS: Using multidisciplinary consensus definitions, proven or probable bCAP was uncommon in adults hospitalized due to COVID-19, as were other nonrespiratory bacterial infections. Empiric antibiotic use was high, highlighting the need to enhance antibiotic stewardship in the treatment of viral pneumonias.
format Online
Article
Text
id pubmed-7793465
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77934652021-01-13 Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study Karaba, Sara M Jones, George Helsel, Taylor Smith, L Leigh Avery, Robin Dzintars, Kathryn Salinas, Alejandra B Keller, Sara C Townsend, Jennifer L Klein, Eili Amoah, Joe Garibaldi, Brian T Cosgrove, Sara E Fabre, Valeria Open Forum Infect Dis Major Articles BACKGROUND: Bacterial infections may complicate viral pneumonias. Recent reports suggest that bacterial co-infection at time of presentation is uncommon in coronavirus disease 2019 (COVID-19); however, estimates were based on microbiology tests alone. We sought to develop and apply consensus definitions, incorporating clinical criteria to better understand the rate of co-infections and antibiotic use in COVID-19. METHODS: A total of 1016 adult patients admitted to 5 hospitals in the Johns Hopkins Health System between March 1, 2020, and May 31, 2020, with COVID-19 were evaluated. Adjudication of co-infection using definitions developed by a multidisciplinary team for this study was performed. Both respiratory and common nonrespiratory co-infections were assessed. The definition of bacterial community-acquired pneumonia (bCAP) included proven (clinical, laboratory, and radiographic criteria plus microbiologic diagnosis), probable (clinical, laboratory, and radiographic criteria without microbiologic diagnosis), and possible (not all clinical, laboratory, and radiographic criteria met) categories. Clinical characteristics and antimicrobial use were assessed in the context of the consensus definitions. RESULTS: Bacterial respiratory co-infections were infrequent (1.2%); 1 patient had proven bCAP, and 11 (1.1%) had probable bCAP. Two patients (0.2%) had viral respiratory co-infections. Although 69% of patients received antibiotics for pneumonia, the majority were stopped within 48 hours in patients with possible or no evidence of bCAP. The most common nonrespiratory infection was urinary tract infection (present in 3% of the cohort). CONCLUSIONS: Using multidisciplinary consensus definitions, proven or probable bCAP was uncommon in adults hospitalized due to COVID-19, as were other nonrespiratory bacterial infections. Empiric antibiotic use was high, highlighting the need to enhance antibiotic stewardship in the treatment of viral pneumonias. Oxford University Press 2020-12-21 /pmc/articles/PMC7793465/ /pubmed/33447639 http://dx.doi.org/10.1093/ofid/ofaa578 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles
Karaba, Sara M
Jones, George
Helsel, Taylor
Smith, L Leigh
Avery, Robin
Dzintars, Kathryn
Salinas, Alejandra B
Keller, Sara C
Townsend, Jennifer L
Klein, Eili
Amoah, Joe
Garibaldi, Brian T
Cosgrove, Sara E
Fabre, Valeria
Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study
title Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study
title_full Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study
title_fullStr Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study
title_full_unstemmed Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study
title_short Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study
title_sort prevalence of co-infection at the time of hospital admission in covid-19 patients, a multicenter study
topic Major Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793465/
https://www.ncbi.nlm.nih.gov/pubmed/33447639
http://dx.doi.org/10.1093/ofid/ofaa578
work_keys_str_mv AT karabasaram prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT jonesgeorge prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT helseltaylor prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT smithlleigh prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT averyrobin prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT dzintarskathryn prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT salinasalejandrab prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT kellersarac prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT townsendjenniferl prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT kleineili prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT amoahjoe prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT garibaldibriant prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT cosgrovesarae prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy
AT fabrevaleria prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy